Laurie Toich, Assistant Editor

New research shows that being married is associated with higher survival rates in cancer patients.

Zinbryta found to reduce cells that contribute to neurological injury caused by multiple sclerosis.

Treating hepatitis C could potentially be less expensive with generic treatments.

Treating hepatitis C could potentially be less expensive with generic treatments.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Eslicarbazepine acetate may help patients adhere to their medication schedule.

Overall positive results shown in studies with Harvoni and sofosbuvir/velpatasvir.

Overall positive results shown in studies with Harvoni and sofosbuvir/velpatasvir.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

RO 48-8971 may inhibit the growth of and kill prostate cancer cells.

Global spending on healthcare expected to exceed $18 trillion over next 25 years.

Two studies produce two very different results treating a hepatitis C-HIV coinfection.

A recent Tecfidera study finds find no rate of relapse of progression in MS patients.

A recent Tecfidera study finds find no rate of relapse of progression in MS patients.

Current steroid treatment may leave patients with cataracts.

Guadecitabine and chemotherapy can potentially overcome treatment resistance.

Top news of the day from across the healthcare landscape.

Pharmacy benefit managers found to help limit spending growth on branded drugs last year.

FDA approved and “breakthrough therapy” are two commonly used phrases in regards to pharmaceuticals, but physicians may not fully understand the meaning of these terms.

Drug resistance is better understood through mapping out alternate paths cancer cells take in order to avoid targeted treatment.

Top news of the day from across the healthcare landscape.

Genetic map may lead to new targeted treatments for scleroderma.

The average deductible jumped from $303 in 2006 to $1077 in 2014.

Discovery may lead to pharmaceutical compounds that target protein structure.

A new study shows that genes can become sensitive to crizotinib after the introduction of ponatinib.

Top news of the day from across the healthcare landscape.

Improving insulin signaling in the brain may reduce the likelihood patients with Alzheimer's disease develop diabetes.

Eight macro-trends for employers to consider when creating a healthcare plan